These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 6508636)
61. A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy. Aguilar-Salinas CA; Hugh P; Barrett R; Pulai J; Zhu XL; Schonfeld G Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):72-82. PubMed ID: 9012640 [TBL] [Abstract][Full Text] [Related]
62. Effects of continuous low-dosage hormonal replacement therapy on lipoprotein metabolism in postmenopausal women. Wolfe BM; Huff MW Metabolism; 1995 Mar; 44(3):410-7. PubMed ID: 7885290 [TBL] [Abstract][Full Text] [Related]
63. Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males. Cuchel M; Schaefer EJ; Millar JS; Jones PJ; Dolnikowski GG; Vergani C; Lichtenstein AH Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1910-7. PubMed ID: 9351353 [TBL] [Abstract][Full Text] [Related]
64. Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia. Schonfeld G; Aguilar-Salina C; Elias N Am J Cardiol; 1998 Feb; 81(4A):43B-46B. PubMed ID: 9526813 [TBL] [Abstract][Full Text] [Related]
65. Metabolism of plasma low density lipoproteins in familial combined hyperlipidaemia: effect of acipimox therapy. Ericsson S; Eriksson M; Berglund L; Angelin B J Intern Med; 1992 Oct; 232(4):313-20. PubMed ID: 1402634 [TBL] [Abstract][Full Text] [Related]
67. Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B. Vega GL; East C; Grundy SM Arteriosclerosis; 1989; 9(1 Suppl):I135-44. PubMed ID: 2912427 [TBL] [Abstract][Full Text] [Related]
68. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia. Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951 [TBL] [Abstract][Full Text] [Related]
69. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages. Milosavljevic D; Griglio S; Le Naour G; Chapman MJ Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449 [TBL] [Abstract][Full Text] [Related]
70. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase. Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025 [TBL] [Abstract][Full Text] [Related]
71. Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease. Kontopoulos AG; Athyros VG; Papageorgiou AA; Hatzikonstandinou HA; Mayroudi MC; Boudoulas H Coron Artery Dis; 1996 Nov; 7(11):843-50. PubMed ID: 8993943 [TBL] [Abstract][Full Text] [Related]
73. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates. Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202 [TBL] [Abstract][Full Text] [Related]
74. Direct synthesis of low-density lipoprotein apoprotein B in the miniature pig. Huff MW; Telford DE Metabolism; 1985 Jan; 34(1):36-42. PubMed ID: 3965861 [TBL] [Abstract][Full Text] [Related]
75. Two patterns of LDL metabolism in normotriglyceridemic patients with hypoalphalipoproteinemia. Vega GL; Grundy SM Arterioscler Thromb; 1993 Apr; 13(4):579-89. PubMed ID: 8466893 [TBL] [Abstract][Full Text] [Related]
76. Change in very low-, low-, and high-density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia. Gavish D; Oschry Y; Fainaru M; Eisenberg S Eur J Clin Invest; 1986 Feb; 16(1):61-8. PubMed ID: 3084275 [TBL] [Abstract][Full Text] [Related]
77. Impaired catabolism of very low-density lipoprotein-triglyceride in a family with primary hypertriglyceridemia. Dunn FL; Grundy SM; Bilheimer DW; Havel RJ; Raskin P Metabolism; 1985 Apr; 34(4):316-24. PubMed ID: 3884962 [TBL] [Abstract][Full Text] [Related]
78. Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial. Furtado JD; Campos H; Appel LJ; Miller ER; Laranjo N; Carey VJ; Sacks FM Am J Clin Nutr; 2008 Jun; 87(6):1623-30. PubMed ID: 18541549 [TBL] [Abstract][Full Text] [Related]
79. Dietary carbohydrate type and fat amount alter VLDL and LDL metabolism in guinea pigs. Fernandez ML; Vergara-Jimenez M; Conde K; Abdel-Fattah G J Nutr; 1996 Oct; 126(10):2494-504. PubMed ID: 8857510 [TBL] [Abstract][Full Text] [Related]
80. Regulation of low density lipoprotein apoprotein B metabolism by lovastatin and cholestyramine in miniature pigs: effects on LDL composition and synthesis of LDL subfractions. Huff MW; Telford DE Metabolism; 1989 Mar; 38(3):256-64. PubMed ID: 2918845 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]